extensive investigation of patients with mild elevations of serum amylase and/or lipase is ‘low yield’
Clicks: 123
ID: 217916
2002
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
0.3
/100
1 views
1 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
BACKGROUND: Serum amylase and lipase levels are widely used as markers of pancreatic inflammation. However, it would seem that mild elevations of amylase and lipase rarely predict significant pancreatic pathology. Pancreatic imaging tests are expensive. The gold standard, endoscopic retrograde cholangiopancreatography, carries risk of morbidity and mortality.| Reference Key |
byrne2002canadianextensive
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Michael F Byrne;Robert M Mitchell;Helen Stiffler;Paul S Jowell;Malcolm S Branch;Theodore N Pappas;Doug Tyler;John Baillie |
| Journal | indian journal of pharmacology |
| Year | 2002 |
| DOI | 10.1155/2002/836012 |
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.